Skip to main content

Table 1 Detection of Panels 6272 and 11,000 by Serological Assays

From: Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors

Assay

First Positive Panel Member

Panel 6272

Panel 11,000

Panel Member

Day

Panel Member

Day

ARCHITECT HBsAg Prototype

12

51

1

0

PreS2 Research Assay

16

65

4

14

ARCHITECT HBsAg Qual. II

20

94

6

21

Elecsys HBsAg II

20

94

6

21

LIAISON XL MUREX HBsAg Quant.

20a

94

6b

21

Lumipulse HBcrAg

21c

97

6d

21

Centaur HBsAg II

21

97

6

21

  1. The ARCHITECT Prototype, PreS2, ARCHITECT Qual.II, Elecsys, and Centaur assays are qualitative; the LIAISON and Lumipulse assays are quantitative
  2. a0.08 IU/ml HBsAg, b0.05 IU/ml HBsAg, c3 U/ml HBcrAg, d3.1 U/ml HBcrAg